Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Worldwide distribution rights of 2 specialty drugs. The rights allows production and sale of Buccastem, used for the treatment of nausea and vomiting, and Timodine, a anti-fungal and anti-bacterial skin cream used for treating inflamed and infected skin conditions.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Healthcare
Acquirer
Primary Office
  • 103 - 105 Bath Road
  • Slough SL1 3UH
  • England, United Kingdom

Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands)‘s full profile, request access.

Request full access to PitchBook

Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands)‘s full profile, request access.

Request full access to PitchBook